Cargando…
MMP-9 plasma level as biomarker of cochlear implantation outcome in cohort study of deaf children
PURPOSE: If before cochlear implantation it was possible to assay biomarkers of neuroplasticity, we might be able to identify those children with congenital deafness who, later on, were at risk of poor speech and language rehabilitation outcomes. METHODS: A group of 40 children aged up to 2 years wi...
Autores principales: | Matusiak, Monika, Oziębło, Dominika, Ołdak, Monika, Rejmak, Emilia, Kaczmarek, Leszek, Dobek, Dominik, Skarżyński, Henryk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497633/ https://www.ncbi.nlm.nih.gov/pubmed/37004521 http://dx.doi.org/10.1007/s00405-023-07924-y |
Ejemplares similares
-
Longitudinal Changes in BDNF and MMP-9 Protein Plasma Levels in Children after Cochlear Implantation
por: Matusiak, Monika, et al.
Publicado: (2023) -
Prospective cohort study reveals MMP-9, a
neuroplasticity regulator, as a prediction marker of cochlear implantation outcome in
prelingual deafness treatment
por: Matusiak, Monika, et al.
Publicado: (2022) -
Functional Polymorphism of MMP9 and BDNF as Potential Biomarker of Auditory Neuroplasticity in Prelingual Deafness Treatment With Cochlear Implantation—A Retrospective Cohort Analysis
por: Matusiak, Monika, et al.
Publicado: (2021) -
Effect on vestibular function of cochlear implantation by partial deafness treatment–electro acoustic stimulation (PDT–EAS)
por: Sosna, Magdalena, et al.
Publicado: (2019) -
Cochlear implants in adults with partial deafness: subjective benefits but associated psychological distress
por: Kobosko, Joanna, et al.
Publicado: (2020)